Retroelement-Linked H3K4me1 Histone Tags Uncover Regulatory Evolution Trends of Gene Enhancers and Feature Quickly Evolving Molecular Processes in Human Physiology.

H3K4me1 enhancers of transcription epigenetics gene expression regulation gene ontology histone modifications human genome evolution molecular pathways retroelements retrotransposons

Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
08 10 2019
Historique:
received: 23 08 2019
revised: 25 09 2019
accepted: 01 10 2019
entrez: 11 10 2019
pubmed: 11 10 2019
medline: 19 5 2020
Statut: epublish

Résumé

Retroelements (REs) are mobile genetic elements comprising ~40% of human DNA. They can reshape expression patterns of nearby genes by providing various regulatory sequences. The proportion of regulatory sequences held by REs can serve a measure of regulatory evolution rate of the respective genes and molecular pathways. We calculated RE-linked enrichment scores for individual genes and molecular pathways based on ENCODE project epigenome data for enhancer-specific histone modification H3K4me1 in five human cell lines. We identified consensus groups of molecular processes that are enriched and deficient in RE-linked H3K4me1 regulation. We calculated H3K4me1 RE-linked enrichment scores for 24,070 human genes and 3095 molecular pathways. We ranked genes and pathways and identified those statistically significantly enriched and deficient in H3K4me1 RE-linked regulation. Non-coding RNA genes were statistically significantly enriched by RE-linked H3K4me1 regulatory modules, thus suggesting their high regulatory evolution rate. The processes of gene silencing by small RNAs, DNA metabolism/chromatin structure, sensory perception/neurotransmission and lipids metabolism showed signs of the fastest regulatory evolution, while the slowest processes were connected with immunity, protein ubiquitination/degradation, cell adhesion, migration and interaction, metals metabolism/ion transport, cell death, intracellular signaling pathways.

Sections du résumé

BACKGROUND
Retroelements (REs) are mobile genetic elements comprising ~40% of human DNA. They can reshape expression patterns of nearby genes by providing various regulatory sequences. The proportion of regulatory sequences held by REs can serve a measure of regulatory evolution rate of the respective genes and molecular pathways.
METHODS
We calculated RE-linked enrichment scores for individual genes and molecular pathways based on ENCODE project epigenome data for enhancer-specific histone modification H3K4me1 in five human cell lines. We identified consensus groups of molecular processes that are enriched and deficient in RE-linked H3K4me1 regulation.
RESULTS
We calculated H3K4me1 RE-linked enrichment scores for 24,070 human genes and 3095 molecular pathways. We ranked genes and pathways and identified those statistically significantly enriched and deficient in H3K4me1 RE-linked regulation.
CONCLUSION
Non-coding RNA genes were statistically significantly enriched by RE-linked H3K4me1 regulatory modules, thus suggesting their high regulatory evolution rate. The processes of gene silencing by small RNAs, DNA metabolism/chromatin structure, sensory perception/neurotransmission and lipids metabolism showed signs of the fastest regulatory evolution, while the slowest processes were connected with immunity, protein ubiquitination/degradation, cell adhesion, migration and interaction, metals metabolism/ion transport, cell death, intracellular signaling pathways.

Identifiants

pubmed: 31597351
pii: cells8101219
doi: 10.3390/cells8101219
pmc: PMC6830109
pii:
doi:

Substances chimiques

Retroelements 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Déclaration de conflit d'intérêts

The authors declare no conflict of interests.

Références

Front Immunol. 2018 Jan 30;9:30
pubmed: 29441061
Cells. 2019 Feb 06;8(2):
pubmed: 30736359
Front Oncol. 2019 Jan 04;8:658
pubmed: 30662873
Annu Rev Biochem. 1988;57:159-97
pubmed: 3052270
J Mol Evol. 2011 Oct;73(3-4):209-20
pubmed: 22057117
Am J Hum Genet. 2018 Feb 1;102(2):207-218
pubmed: 29357977
Trends Genet. 2016 Dec;32(12):801-814
pubmed: 27816209
Genome Res. 2012 Oct;22(10):2043-53
pubmed: 22593555
Nucleic Acids Res. 2017 Mar 17;45(5):2408-2422
pubmed: 27932482
Genome Res. 2007 Jun;17(6):787-97
pubmed: 17567997
Curr Opin Genet Dev. 2017 Apr;43:110-119
pubmed: 28359978
Mol Biol Evol. 2018 Aug 1;35(8):1947-1957
pubmed: 29762743
Mol Cell. 2013 Mar 7;49(5):825-37
pubmed: 23473601
Curr Opin Genet Dev. 2012 Jun;22(3):191-203
pubmed: 22406018
Methods Mol Biol. 2017;1446:189-205
pubmed: 27812944
Nat Genet. 2012 Jan 08;44(2):148-56
pubmed: 22231485
Trends Genet. 2018 Jul;34(7):532-544
pubmed: 29680748
Am J Physiol. 1989 Jan;256(1 Pt 2):R63-9
pubmed: 2536249
Philos Trans R Soc Lond B Biol Sci. 2013 Nov 11;368(1632):20130017
pubmed: 24218630
Proc Natl Acad Sci U S A. 2016 May 10;113(19):E2617-26
pubmed: 27114548
Science. 2016 Mar 4;351(6277):1083-7
pubmed: 26941318
Annu Rev Genet. 2012;46:1-19
pubmed: 22905871
Mol Cells. 2017 Mar;40(3):169-177
pubmed: 28359147
Curr Opin Genet Dev. 2016 Apr;37:90-100
pubmed: 26855260
Chem Rev. 2006 Feb;106(2):720-52
pubmed: 16464022
Cell Mol Life Sci. 2009 Dec;66(23):3727-42
pubmed: 19649766
Cancer Inform. 2019 Mar 25;18:1176935119838844
pubmed: 30936679
Nucleic Acids Res. 2016 Jan 4;44(D1):D481-7
pubmed: 26656494
Trends Cell Biol. 2013 Jul;23(7):345-56
pubmed: 23566594
Nature. 2012 Sep 6;489(7414):57-74
pubmed: 22955616
Nat Rev Genet. 2012 Sep;13(9):613-26
pubmed: 22868264
Methods Mol Biol. 2017;1468:91-109
pubmed: 27662872
Nature. 2009 May 7;459(7243):108-12
pubmed: 19295514
Proc Natl Acad Sci U S A. 2013 Nov 26;110(48):19472-7
pubmed: 24218577
Cell. 2016 Nov 17;167(5):1170-1187
pubmed: 27863239
J Exp Biol. 1989 Sep;146:165-76
pubmed: 2689560
Nucleic Acids Res. 2009 Jan;37(1):1-13
pubmed: 19033363
Nat Commun. 2018 Oct 4;9(1):4066
pubmed: 30287902
Semin Cancer Biol. 2018 Dec;53:110-124
pubmed: 29935311
PLoS Genet. 2013 Mar;9(3):e1003402
pubmed: 23555307
Cell Mol Life Sci. 2015 Oct;72(19):3653-75
pubmed: 26082181
PLoS Biol. 2018 Sep 19;16(9):e2006337
pubmed: 30231016
Biochim Biophys Acta. 2015 Aug;1849(8):1116-31
pubmed: 25934543
Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16337-42
pubmed: 17060629
Nature. 2001 Feb 15;409(6822):860-921
pubmed: 11237011
Am J Med Genet B Neuropsychiatr Genet. 2015 Oct;168(7):517-27
pubmed: 26059482
Eur J Immunol. 2013 Apr;43(4):867-77
pubmed: 23440773
Pflugers Arch. 2016 Jun;468(6):1049-60
pubmed: 27044413
Cell Rep. 2017 Dec 5;21(10):2879-2894
pubmed: 29212033
Genes Genomics. 2016;38:779-791
pubmed: 27594978
Adv Immunol. 2017;133:121-169
pubmed: 28215278
Int J Mol Sci. 2017 Sep 16;18(9):null
pubmed: 28926941
Nucleic Acids Res. 2000 Jan 1;28(1):27-30
pubmed: 10592173
Methods Mol Biol. 2017;1613:31-51
pubmed: 28849557
J Intern Med. 2014 Sep;276(3):201-14
pubmed: 24605849
Dev Biol. 2017 Jul 15;427(2):193-202
pubmed: 27880868

Auteurs

Daniil Nikitin (D)

Group for genomic analysis of cell signaling systems, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, 117997 Moscow, Russia. danya.nikitin.orel@gmail.com.
Omicsway Corp., Walnut, CA 91789, USA. danya.nikitin.orel@gmail.com.

Nikita Kolosov (N)

ITMO University, 195251 Saint-Petersburg, Russia. nikita-kolosov@yandex.ru.

Anastasiia Murzina (A)

ITMO University, 195251 Saint-Petersburg, Russia. murzinanastasiia@gmail.com.

Karina Pats (K)

ITMO University, 195251 Saint-Petersburg, Russia. karina.m.pats@gmail.com.

Anton Zamyatin (A)

ITMO University, 195251 Saint-Petersburg, Russia. zamyatin.anton@gmail.com.

Victor Tkachev (V)

Omicsway Corp., Walnut, CA 91789, USA. tkachev@oncobox.com.

Maxim Sorokin (M)

Omicsway Corp., Walnut, CA 91789, USA. sorokin@oncobox.com.
Institute of Personalized Medicine, I.M. Sechenov First Moscow State Medical University, 119991 Moscow, Russia. sorokin@oncobox.com.

Philippe Kopylov (P)

Institute of Personalized Medicine, I.M. Sechenov First Moscow State Medical University, 119991 Moscow, Russia. fjk@inbox.ru.

Anton Buzdin (A)

Group for genomic analysis of cell signaling systems, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, 117997 Moscow, Russia. buzdin@oncobox.com.
Omicsway Corp., Walnut, CA 91789, USA. buzdin@oncobox.com.
Institute of Personalized Medicine, I.M. Sechenov First Moscow State Medical University, 119991 Moscow, Russia. buzdin@oncobox.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH